European Heart Journal
Semaglutide, independent of weight loss, attenuates cardiac and hepatic remodelling in experimental heart failure with preserved ejection fraction
Experiments in animalsInterventions
Papers by Edwin Yoo
2 results
- AHA Scientific Sessions 2025 Abstract
Semaglutide Modulates the Cardio-Hepatic Axis By Mitigating Lipid and Fibrosis Deposition Independent of Weight Loss in Obese HFpEF
Experiments in animalsInterventions